Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Y Shin

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationshipY G Suh, Y H Kim, M H Park, et al.
European Review for Medical and Pharmacological Sciences|December 17, 2021
Anti-diabetic effects of Protaetia brevitarsis in pancreatic islets and a murine diabetic modelY M Park, E-M Noh, H Y Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomasS J Kim, D-Y Shin, J S Kim, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 10, 2020
Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trialJ-H Kim, I Kim, C K Kang, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationshipY G Suh, Y H Kim, M H Park, et al.
European Review for Medical and Pharmacological Sciences|December 17, 2021
Anti-diabetic effects of Protaetia brevitarsis in pancreatic islets and a murine diabetic modelY M Park, E-M Noh, H Y Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomasS J Kim, D-Y Shin, J S Kim, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 10, 2020
Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trialJ-H Kim, I Kim, C K Kang, et al.
Pageof 4